White Matter Hyperintensities and Cerebral Amyloidosis
Frank A. Provenzano(Brigham and Women's Hospital), for the Alzheimer’s Disease Neuroimaging Initiative, Adam M. Brickman(Columbia University), Jordan Muraskin(University of Cambridge), Irene B. Meier(Museum of Fine Arts, Houston), Molly E. Zimmerman(Albert Einstein College of Medicine), Ben T. Wasserman(Columbia University), Atul Narkhede(Columbia University), Vanessa A. Guzman(Columbia University), Erica Y. Griffith(Columbia University), Giuseppe Tosto(NewYork–Presbyterian Hospital)
Cited by 194
Related Papers
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network
|Annals of Neurology|2016|553
Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease
|Proceedings of the National Academy of Sciences|2013|388
Plasma p‐tau181, p‐tau217, and other blood‐based Alzheimer's disease biomarkers in a multi‐ethnic, community study
|Alzheimer s & Dementia|2021|388
Novel genetic loci associated with hippocampal volume
|Nature Communications|2017|335